Novo Nordisk A-S
Price & Volume
Stats
See more52W Range | $34.58-$68.48 |
Market Cap | $218.9B |
Shares Short | 27M |
Financials
See moreRevenue (12 Mos) | $327.7B |
Revenue Growth (YoY) | 24% |
Gross Profit (12 Mos) | $272.7B |
Diluted EPS | $4.17 |
News
See moreYahoo Finance • 17 hours ago
Novo Nordisk (CPSE:NOVO B) Reports Fresh Hemophilia Trial Wins In Adults And Children
Yahoo Finance • 22 hours ago
Is This Disturbing Trend Bad News for Eli Lilly in the Billion-Dollar Obesity Drug Market?
Yahoo Finance • yesterday
Global Blood Glucose Monitoring System Market Size to Reach USD 39.4 Billion by 2035 | Growing at 8.9% CAGR | Industry Trends, Market Share & Forecast – Custom Market Insights
Yahoo Finance • 2 days ago
Novo Nordisk A/S - share repurchase programme
About
CEO | Mr. Maziar Mike Doustdar B.A. |
CFO | Mr. Karsten Munk Knudsen |
Address | Novo Alle 1, Bagsvaerd, Denmark, 2880 |
Sector | Healthcare |
Industry | Drug Manufacturers - General |
Full-Time Employees | 67,900 |